Literature DB >> 7623436

Severely depressed natural killer cell activity of patients with adrenoleukodystrophy under treatment with Lorenzo's oil.

P Sedlmayr1, B Plecko, E Paschke, W Zenz, H Ramschak, H Toplak, T C Wascher, M Wilders-Truschnig, S Stöckler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7623436     DOI： 10.1007/bf00711394

Source DB:  PubMed          Journal:  J Inherit Metab Dis        ISSN： 0141-8955            Impact factor:   4.982


× No keyword cloud information.
  3 in total

1.  Reduced stimulability of platelet surface adhesion molecules under treatment with Lorenzo's oil.

Authors:  H Toplak; T C Wascher; B Pleschko; H Ramschak; P Sedlmayr; M Wilders-Truschnigg; S Stöckler
Journal:  J Inherit Metab Dis       Date:  1994       Impact factor: 4.982

Review 2.  Natural killer cytotoxicity in the diagnosis of immune dysfunction: criteria for a reproducible assay.

Authors:  T L Whiteside; J Bryant; R Day; R B Herberman
Journal:  J Clin Lab Anal       Date:  1990       Impact factor: 2.352

3.  A two-year trial of oleic and erucic acids ("Lorenzo's oil") as treatment for adrenomyeloneuropathy.

Authors:  P Aubourg; C Adamsbaum; M C Lavallard-Rousseau; F Rocchiccioli; N Cartier; I Jambaqué; C Jakobezak; A Lemaitre; F Boureau; C Wolf
Journal:  N Engl J Med       Date:  1993-09-09       Impact factor: 91.245
  3 in total
  3 in total

1.  Progression of abnormalities in adrenomyeloneuropathy and neurologically asymptomatic X-linked adrenoleukodystrophy despite treatment with "Lorenzo's oil".

Authors:  B M van Geel; J Assies; E B Haverkort; J H Koelman; B Verbeeten; R J Wanders; P G Barth
Journal:  J Neurol Neurosurg Psychiatry       Date:  1999-09       Impact factor: 10.154

2.  Enhanced lymphocyte proliferation in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.

Authors:  R B Pour; S Stöckler-Ipsiroglu; D H Hunneman; M Gahr; G C Korenke; W Pabst; F Hanefeld; A Peters
Journal:  J Inherit Metab Dis       Date:  2000-03       Impact factor: 4.982

3.  Decreased platelet membrane anisotropy in patients with adrenoleukodystrophy treated with erucic acid (22:1)-rich triglycerides.

Authors:  S Stöckler; C Opper; A Greinacher; D H Hunneman; G C Korenke; C J Unkrig; F Hanefeld
Journal:  J Inherit Metab Dis       Date:  1997-03       Impact factor: 4.982
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.